Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy

Detalles Bibliográficos
Autores principales: Longcor, Jarrod, Callander, Natalie, Oliver, Kate, Chanan-Khan, Asher, Ailawadhi, Sikander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448804/
https://www.ncbi.nlm.nih.gov/pubmed/36068232
http://dx.doi.org/10.1038/s41408-022-00725-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448804/
https://www.ncbi.nlm.nih.gov/pubmed/36068232
http://dx.doi.org/10.1038/s41408-022-00725-2

Ejemplares similares